Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Renitec TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: enalapril
Brand name
(ARTG)
: RENITEC enalapril maleate 10mg tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
HYPERTENSION: Renitec is indicated in the treatment of: - all grades of essential hypertension; - Renovascular hypertension. CONGESTIVE HEART FAILURE: Renitec is indicated for the treatment of all degrees of symptomatic heart failure. In such patients, it is recommended that RENITEC be administered together with a diuretic. LEFT VENTRICULAR DYSFUNCTION: All degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, uncoated
- Oral
- Rust red, barrel shaped tablet. One side "RENITEC", and the other side scored
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient enalapril
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.